Page last updated: 2024-08-23

bromocriptine and carbidopa

bromocriptine has been researched along with carbidopa in 104 studies

Research

Studies (104)

TimeframeStudies, this research(%)All Research%
pre-199074 (71.15)18.7374
1990's19 (18.27)18.2507
2000's10 (9.62)29.6817
2010's1 (0.96)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Quik, M; Sourkes, TL1
Winkelman, AC1
Rinne, UK1
Calne, DB; Gielen, AC; Gillespie, MM; Kartzinel, R; Perlow, M; Sadowsky, DA; TEYCHENNE, P1
Lipper, S1
Caine, E; Carter, AC; Ebert, M; Kartzinel, R1
Battista, AF; Goldstein, M; Lew, JY; Lieberman, A; Matsumoto, Y1
Caine, ED; Davis, GC; Ebert, MH; Kopin, IJ; Markey, SP; Reichert, CM; Williams, AC1
Estey, E; Goldstein, M; Gopinathan, G; Kupersmith, M; Lieberman, A1
Albizzati, MG; Frattola, L; Scarlato, G; Trabucchi, M1
List, SJ; Seeman, P1
Bender, DA; Earl, CJ; Lees, AJ1
Carolei, A; Masturzo, P; Murialdo, G; Polleri, A1
Estey, E; Goldstein, M; Goodgold, A; Gopinathan, G; Kupersmith, M; Lieberman, AN1
Fahn, S; Hutt, CS; Snider, SR1
Johnels, B; Steg, G; Ungerstedt, U1
Bern, SM; Calne, DB; McInturff, D; Pfeiffer, RF; Teychenne, PF1
Haddad, S; Kohout, LJ; Lees, AJ; Shaw, KM; Stern, GM1
Ward, HW1
Calne, DB; Pfeiffer, RF; Teychenne, PF1
Reid, WG1
Graff, E; Korczyn, AD; Rabey, JM; Shabtai, H; Vered, Y1
Jacobs, MB; Varon, J1
Bédard, PJ; Di Paolo, T; Gagnon, C1
Cowan, A1
Calne, DB; Calne, S; Douglas, J; Postnikoff, D; Poulin, K; Ross, S; Tsui, JK; Woodward, W1
Broe, GA; Genge, S; Hely, MA; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM2
Munitz, H; Shalev, A1
Cummings, JL; Friedenberg, DL1
Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA1
Herskovits, E; Leston, J; Yorio, A1
Birkmayer, JD; Birkmayer, W1
Braz, S; Ferreira, TM; Silveira Filho, NG; Troncone, LR; Tufik, S1
Bouchard, S; Gawel, MJ; Libman, I; Riopelle, RJ1
Allain, H; Bentué-Ferrer, D; Reymann, JM; Sabouraud, O; Van den Driessche, J1
Ijichi, H; Ikegaiki, I; Kambara, S; Matsuzawa, M; Okabayashi, H; Suga, K; Takahashi, H; Yoshimura, M1
Ijichi, H; Takahasi, H; Takashina, R; Yoshimura, M1
Agniel, A; Celsis, P; Demonet, JF; Doyon, B; Marc-Vergnes, JP; Montastruc, JL; Puel, M; Rascol, A1
Bouchard, S; Gawel, M; Libman, I; Riopelle, R1
Sandyk, R2
Lazarus, A1
Muenter, MD2
Klawans, HL; Paleologos, N1
Wilson, JA1
Calne, DB; Glover, R; Lau, E; Schulzer, M; Waterman, K1
Boyce, S; De Ceballos, ML; Jenner, P; Marsden, CD1
Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J1
van der Drift, JH1
Feldman, RG; Lannon, MC1
Boiadzhieva, N; Ovcharov, R; Zakharieva, B1
Wirz, D1
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G1
Hoehn, MM1
Ross, ED; Stewart, RM1
Enna, SJ; Lake, CR; Teychenné, PF; Ziegler, MG1
Alonso, RJ; Covington, TR; Mancall, EL1
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L1
Armstrong, D; Courtney, CL; Palfai, T1
Calne, DB; Larsen, TA; LeWitt, P; Newman, R1
Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S1
Calne, DB; Eisler, T; Kaiser, DL; MacLeod, RM; Thorner, MO1
Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Neophytides, A; Walker, R1
Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Toone, B1
Calne, DB; Le Witt, PA1
Goetz, CG; Nausieda, PA; Tanner, CM1
Kaplan, LR; Klawans, HL; Nausieda, PA; Weber, S; Weiner, WJ1
Lieberman, AN; Plasse, HM1
Grimes, JD; Hassan, MN1
Stewart, RM1
Barrett, RE; Côté, LJ; Fahn, S; Snider, SR1
Lander, CM; Lees, AJ; Shaw, KM; Stern, GM1
Duvoisin, RC; Mendoza, MM; Yahr, MD1
Bushenbark, K; Esterlitz, J; Gauger, L; Hauser, RA; Hubble, J; Koller, W; Lilienfeld, D; Malapira, T; Olanow, CW1
Asanuma, M; Kawai, M; Kohno, M; Masumizu, T; Mori, A; Ogawa, N; Tanaka, K1
Broe, GA; Hely, MA; Margrie, S; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM1
Abraham, OC; Archana, S; Cherian, AM; Kurien, T; Rajeev, KK1
Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR1
Lauterbach, EC1
Comella, CL; Ristanovic, RK; Tanner, CM1
Lieberman, A1
Amiel, C; Comoy, E; Couette, S; Friedlander, G; Garcia-Ocaña, A; Perrichot, R1
Ahlskog, JE1
McCallum, RW; Sarosiek, I; Shifflett, J; Soykan, I; Wooten, GF1
Araki, T; Itoyama, Y; Kobayashi, T; Ohta, T; Oshima, Y; Takeshita, M1
Amano, K; Takakura, K1
Adair, JC; Davis, LE1
Busenbark, K; Hauser, RA; Hubble, JP; Koller, WC; Malapira, T; Olanow, CW1
Milkov, V; Miteva, K; Pironcheva, G; Russev, G; Zlatarev, S1
Haapaniemi, TH; Korpelainen, JT; Myllylä, VV; Sotaniemi, KA; Suominen, K; Tolonen, U1
Susman, VL1
Bar-Gad, I; Bergman, H; Goldberg, JA; Heimer, G1
Hauser, RA; Holford, NH1
Reingardiene, D1
Kim, JM; Kim, KW; Kim, YY; Park, HY1

Reviews

8 review(s) available for bromocriptine and carbidopa

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Recent advances in research on Parkinsonism.
    Acta neurologica Scandinavica. Supplementum, 1978, Volume: 67

    Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase

1978
The neuroleptic malignant syndrome: agent and host interaction.
    Acta psychiatrica Scandinavica, 1986, Volume: 73, Issue:4

    Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome

1986
Update on the treatment of Parkinson's disease.
    Connecticut medicine, 1985, Volume: 49, Issue:10

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Synergism; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline; Time Factors

1985
The pharmacology of Parkinson's disease: basic aspects and recent advances.
    Experientia, 1984, Nov-15, Volume: 40, Issue:11

    Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine

1984
Treatment of early Parkinson's disease: are complicated strategies justified?
    Mayo Clinic proceedings, 1996, Volume: 71, Issue:7

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Selegiline

1996
Clinical management of neuroleptic malignant syndrome.
    The Psychiatric quarterly, 2001,Winter, Volume: 72, Issue:4

    Topics: Bromocriptine; Carbidopa; Dopamine Agonists; Drug Combinations; Electroconvulsive Therapy; Guidelines as Topic; Humans; Levodopa; Neuroleptic Malignant Syndrome; Physical Therapy Specialty

2001
[Neuroleptic malignant syndrome].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:1

    Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis

2002

Trials

22 trial(s) available for bromocriptine and carbidopa

ArticleYear
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
    Lancet (London, England), 1976, Aug-07, Volume: 2, Issue:7980

    Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors

1976
Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release.
    Life sciences, 1978, Volume: 22, Issue:10

    Topics: Adult; Bromocriptine; Carbidopa; Chlorpromazine; Dopamine; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Placebos; Prolactin; Time Factors

1978
Experimental and clinical studies on bromocriptine in the Parkinsonian syndrome.
    Acta endocrinologica. Supplementum, 1978, Volume: 216

    Topics: Animals; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease, Secondary; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine

1978
Treatment of Parkinson's disease with lergotrile mesylate.
    JAMA, 1977, Nov-28, Volume: 238, Issue:22

    Topics: Acetonitriles; Antiparkinson Agents; Bromocriptine; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease

1977
Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
    Clinical oncology, 1977, Volume: 3, Issue:1

    Topics: Aged; Breast Neoplasms; Bromocriptine; Carbidopa; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Levodopa; Middle Aged; Nausea; Prolactin; Remission, Spontaneous; Stilbenes; Tamoxifen; Time Factors; Vomiting

1977
The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes.
    International psychogeriatrics, 1992, Volume: 4 Suppl 2

    Topics: Age Factors; Aged; Bromocriptine; Carbidopa; Dementia; Drug Therapy, Combination; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease

1992
The effect of dietary protein on the efficacy of L-dopa: a double-blind study.
    Neurology, 1989, Volume: 39, Issue:4

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dietary Proteins; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Selegiline

1989
The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.
    Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:3

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation

1989
Long term bromocriptine treatment in de novo parkinsonian patients.
    Medicina, 1988, Volume: 48, Issue:4

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation

1988
A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:4

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Neurologic Examination; Parkinson Disease

1987
Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
    Advances in neurology, 1987, Volume: 45

    Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation

1987
The Sydney multicentre study of Parkinson's disease. The first 18 months.
    The Medical journal of Australia, 1987, Feb-16, Volume: 146, Issue:4

    Topics: Australia; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans; Levodopa; Parkinson Disease

1987
Prolactin secretion in Parkinson disease.
    Neurology, 1981, Volume: 31, Issue:10

    Topics: Adult; Aged; Blood-Brain Barrier; Bromocriptine; Carbidopa; Dopamine; Drug Combinations; Female; Humans; Hypothalamus, Anterior; Levodopa; Male; Middle Aged; Parkinson Disease; Pituitary Gland; Placebos; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone

1981
Recent advances in the treatment of Parkinson's disease: the role of bromocriptine.
    Journal of neural transmission, 1981, Volume: 51, Issue:1-2

    Topics: Bromocriptine; Carbidopa; Clinical Trials as Topic; Follow-Up Studies; Humans; Levodopa; Parkinson Disease

1981
Weekly drug holiday in Parkinson disease.
    Neurology, 1981, Volume: 31, Issue:11

    Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1981
The effect of deprenyl and levodopa on the progression of Parkinson's disease.
    Annals of neurology, 1995, Volume: 38, Issue:5

    Topics: Aged; Analysis of Variance; Antiparkinson Agents; Bromocriptine; Carbidopa; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Least-Squares Analysis; Levodopa; Male; Parkinson Disease; Prospective Studies; Selegiline; Statistics, Nonparametric; Treatment Outcome

1995
The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:8

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prevalence; Prospective Studies; Severity of Illness Index; Survival Analysis; Treatment Failure

1994
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Domperidone; Dopamine Antagonists; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Severity of Illness Index

1997
Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist?
    Stereotactic and functional neurosurgery, 1997, Volume: 69, Issue:1-4 Pt 2

    Topics: Aged; Aged, 80 and over; Bromocriptine; Carbidopa; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Stereotaxic Techniques; Treatment Outcome

1997
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:3

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies; Selegiline; Substance Withdrawal Syndrome

2000
Suppressed sympathetic skin response in Parkinson disease.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2000, Volume: 10, Issue:6

    Topics: Acoustic Stimulation; Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Electric Stimulation; Evoked Potentials; Evoked Potentials, Auditory; Female; Foot; Hand; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reaction Time; Reference Values; Selegiline; Skin; Sympathetic Nervous System

2000
Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:5

    Topics: Activities of Daily Living; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Withholding Treatment

2002

Other Studies

74 other study(ies) available for bromocriptine and carbidopa

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
    Journal of neurochemistry, 1977, Volume: 28, Issue:1

    Topics: 5-Hydroxytryptophan; 5,6-Dihydroxytryptamine; Adrenal Glands; Animals; Apomorphine; Bromocriptine; Carbidopa; Clonidine; Dopamine; Drug Interactions; Haloperidol; Hydroxydopamines; Injections, Intraventricular; Kinetics; Levodopa; Male; Piribedil; Pituitary Gland; Rats; Serotonin; Serotonin Antagonists; Splanchnic Nerves; Tyrosine 3-Monooxygenase

1977
Update on drug treatment of Parkinsonism.
    American family physician, 1977, Volume: 16, Issue:1

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease

1977
Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa.
    Lancet (London, England), 1976, Sep-11, Volume: 2, Issue:7985

    Topics: Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease; Schizophrenia, Paranoid

1976
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.
    Psychiatry research, 1979, Volume: 1, Issue:3

    Topics: Adult; Bromocriptine; Carbidopa; Chronic Disease; Humans; Levodopa; Locus Coeruleus; Male; Meperidine; Opioid-Related Disorders; Parkinson Disease, Secondary; Substantia Nigra

1979
Hemiparkinsonism. A human model for studying dopaminergic supersensitivity.
    Archives of neurology, 1979, Volume: 36, Issue:4

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Dextroamphetamine; Disease Models, Animal; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease, Secondary; Receptors, Dopamine

1979
Drugs for parkinsonism.
    The Medical letter on drugs and therapeutics, 1979, May-04, Volume: 21, Issue:9

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease

1979
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
    Life sciences, 1979, Apr-16, Volume: 24, Issue:16

    Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Drug; Spiperone

1979
Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa.
    Clinical science (London, England : 1979), 1979, Volume: 56, Issue:1

    Topics: Adolescent; Adult; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Hydrazines; Levodopa; Male; Micrococcus; Middle Aged; Nicotinamidase; Nicotinic Acids; Parkinson Disease; Tryptophan

1979
Effects of the inhibition of aromatic aminoacids decarboxylase on prolactin secretion in humans.
    Bollettino della Societa italiana di biologia sperimentale, 1979, Feb-28, Volume: 55, Issue:4

    Topics: Adult; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Bromocriptine; Carbidopa; Dopamine; Female; Humans; Prolactin

1979
Bromocriptine in Parkinson disease: further studies.
    Neurology, 1979, Volume: 29, Issue:3

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1979
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
    Neurology, 1977, Volume: 27, Issue:6

    Topics: Animals; Brain; Bromocriptine; Carbidopa; Dopamine; Drug Interactions; Ergolines; gamma-Aminobutyric Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Rats; Serotonin

1977
A method for mechanographical recording of muscle tone in the rat: the effect of some antiparkinsonian drugs on rigidity induced by reserpine.
    Brain research, 1978, Jan-20, Volume: 140, Issue:1

    Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Carbidopa; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Male; Muscle Rigidity; Muscle Tonus; Myography; Rats; Reserpine

1978
Comparison between lergotrile and bromocriptine in parkinsonism.
    Annals of neurology, 1978, Volume: 3, Issue:4

    Topics: Acetonitriles; Adult; Aged; Bromocriptine; Carbidopa; Chemical Phenomena; Chemistry; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine

1978
Bromocriptine in parkinsonism. A long-term study.
    Archives of neurology, 1978, Volume: 35, Issue:8

    Topics: Anorexia; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease; Time Factors; Urinary Incontinence; Vasomotor System

1978
Treatment of parkinsonism.
    Advances in experimental medicine and biology, 1977, Volume: 90

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Carbidopa; Dopamine; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine

1977
Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:8

    Topics: Aged; Bromocriptine; Carbidopa; Combined Modality Therapy; Fabaceae; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Plants, Medicinal

1992
Treating the progressive stages of Parkinson's disease.
    Postgraduate medicine, 1991, Volume: 90, Issue:1

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline

1991
Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.
    European journal of pharmacology, 1990, Mar-13, Volume: 178, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autoradiography; Brain; Bromocriptine; Carbidopa; Catecholamines; Dopamine Agents; Female; Levodopa; Macaca fascicularis; Receptors, Dopamine; Spiperone

1990
A view from inside.
    British dental journal, 1990, Sep-22, Volume: 169, Issue:6

    Topics: Accidental Falls; Antiparkinson Agents; Bromocriptine; Carbidopa; Dentists; Drug Combinations; Humans; Levodopa; Male; Northern Ireland; Parkinson Disease

1990
Parkinson's disease, depression, and the on-off phenomenon.
    Psychosomatics, 1989,Winter, Volume: 30, Issue:1

    Topics: Bromocriptine; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease

1989
Comprehensive care of the patient with Parkinson's disease.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1986, Volume: 18, Issue:3

    Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor

1986
Current and future approaches to therapy.
    Advances in neurology, 1987, Volume: 45

    Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Selegiline

1987
Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Psychopharmacology, 1988, Volume: 94, Issue:1

    Topics: Aggression; Amphetamine; Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Imipramine; Levodopa; Male; Nomifensine; Rats; Rats, Inbred Strains; Sleep Deprivation; Sleep, REM; Stereotyped Behavior

1988
Drugs for parkinsonism.
    The Medical letter on drugs and therapeutics, 1988, Dec-16, Volume: 30, Issue:781

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline

1988
International symposium on early dopamine agonist therapy of Parkinson's disease.
    Archives of neurology, 1988, Volume: 45, Issue:2

    Topics: Animals; Bromocriptine; Carbidopa; Dopamine; Humans; Levodopa; Parkinson Disease; Pergolide; Time Factors

1988
Lack of pharmacokinetic influence on levodopa by bromocriptine.
    Clinical neuropharmacology, 1988, Volume: 11, Issue:1

    Topics: Bromocriptine; Carbidopa; Chromatography, High Pressure Liquid; Drug Interactions; Female; Humans; Levodopa; Middle Aged; Parkinson Disease

1988
Pathophysiological role of dopamine on the development of hypertension in rats.
    Japanese circulation journal, 1987, Volume: 51, Issue:10

    Topics: Animals; Blood Pressure; Bromocriptine; Carbidopa; Desoxycorticosterone; Dopamine; Dopamine Antagonists; Epinephrine; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred SHR; Sodium; Sodium, Dietary

1987
Role of renal nerves and dopamine on prostaglandin E release from the kidney of rats.
    Agents and actions. Supplements, 1987, Volume: 22

    Topics: Animals; Bromocriptine; Carbidopa; Denervation; Dopamine; Kidney; Male; Natriuresis; Prostaglandins E; Rats; Sodium

1987
Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
    Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:4

    Topics: Administration, Oral; Aged; Bromocriptine; Carbidopa; Cerebrovascular Circulation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Regional Blood Flow; Tomography, Emission-Computed

1987
Excessive yawning and progressive supranuclear palsy.
    The International journal of neuroscience, 1987, Volume: 34, Issue:1-2

    Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Middle Aged; Supranuclear Palsy, Progressive; Yawning

1987
Therapy of neuroleptic malignant syndrome.
    Psychiatric developments, 1986,Spring, Volume: 4, Issue:1

    Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine

1986
Pharmacotherapy: problems and practices.
    Clinical neuropharmacology, 1986, Volume: 9 Suppl 1

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease

1986
L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine.
    Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:3

    Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Interactions; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Serotonin

1986
Drugs for parkinsonism.
    The Medical letter on drugs and therapeutics, 1986, Jun-20, Volume: 28, Issue:716

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease

1986
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Clinical neuropharmacology, 1986, Volume: 9, Issue:3

    Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis

1986
Management of Parkinson's disease in general practice.
    Scottish medical journal, 1986, Volume: 31, Issue:2

    Topics: Aged; Benserazide; Bromocriptine; Carbidopa; Drug Combinations; Family Practice; Humans; Levodopa; Medical Audit; Parkinson Disease

1986
Effect of antacid on levodopa therapy.
    Clinical neuropharmacology, 1986, Volume: 9, Issue:5

    Topics: Aluminum Hydroxide; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Drug Interactions; Humans; Levodopa; Magnesium; Magnesium Hydroxide; Parkinson Disease

1986
Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats.
    European journal of pharmacology, 1986, Nov-04, Volume: 130, Issue:3

    Topics: Animals; Basal Ganglia; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Male; Neurotensin; Pergolide; Rats; Rats, Inbred Strains; Trifluoperazine

1986
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
    Acta neurologica Scandinavica, 1986, Volume: 74, Issue:4

    Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats

1986
Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study.
    Advances in neurology, 1987, Volume: 45

    Topics: Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease

1987
Parkinson disease. Individualizing therapy.
    Hospital practice (Office ed.), 1985, Jan-15, Volume: 20, Issue:1

    Topics: Aged; Bromocriptine; Carbidopa; Central Nervous System Diseases; Diagnosis, Differential; Gait; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychoses, Substance-Induced; Tremor

1985
[Effect of dopaminergic pharmacological agents on thyrotropic hormone secretion by the hypophysis when stimulated with thyrotropin-releasing hormone].
    Eksperimentalna meditsina i morfologiia, 1985, Volume: 24, Issue:1

    Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Haloperidol; Levodopa; Male; Pituitary Gland; Rats; Thyrotropin; Thyrotropin-Releasing Hormone

1985
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
    Neurology, 1985, Volume: 35, Issue:2

    Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine

1985
Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson's disease.
    Acta neurologica Scandinavica, 1985, Volume: 71, Issue:2

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease

1985
Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists.
    Neurology, 1981, Volume: 31, Issue:11

    Topics: Adult; Akinetic Mutism; Bromocriptine; Carbidopa; Ergolines; Humans; Hypothalamic Neoplasms; Hypothalamus; Levodopa; Male; Methylphenidate; Postoperative Complications

1981
Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon.
    Annals of neurology, 1982, Volume: 11, Issue:1

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Female; gamma-Aminobutyric Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Radioligand Assay

1982
Therapy of neurologic disorders in the elderly.
    Hospital practice (Office ed.), 1984, Volume: 19, Issue:10

    Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Interactions; Heparin; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Trihexyphenidyl

1984
Effect of l-dopa or bromocriptine on feeding and motor behavior of rats with lesions in the globus pallidus.
    Physiology & behavior, 1984, Volume: 33, Issue:2

    Topics: Animals; Body Weight; Brain Mapping; Bromocriptine; Carbidopa; Drinking; Eating; Globus Pallidus; Hydroxydopamines; Levodopa; Male; Motor Activity; Neural Pathways; Oxidopamine; Rats; Receptors, Dopamine; Sex Factors

1984
Severity of Parkinson's disease and the dosage of bromocriptine.
    Neurology, 1984, Volume: 34, Issue:6

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies

1984
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
    Progress in clinical and biological research, 1980, Volume: 39

    Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor

1980
Bromocriptine and lisuride in Parkinson disease.
    Annals of neurology, 1983, Volume: 13, Issue:1

    Topics: Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease

1983
Dopa dose-dependent sexual deviation.
    The British journal of psychiatry : the journal of mental science, 1983, Volume: 142

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Humans; Male; Middle Aged; Paraphilic Disorders; Parkinson Disease; Pergolide

1983
Initial treatment of Parkinson's disease.
    Clinical neuropharmacology, 1982, Volume: 5 Suppl 1

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Prognosis

1982
Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.
    Clinical neuropharmacology, 1982, Volume: 5, Issue:2

    Topics: Aged; Bromocriptine; Carbidopa; Dreams; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Sleep Stages

1982
Bilateral vocal cord paralysis in Parkinson's disease.
    Archives of otolaryngology (Chicago, Ill. : 1960), 1981, Volume: 107, Issue:4

    Topics: Aged; Bromocriptine; Carbidopa; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tracheotomy; Vocal Cord Paralysis

1981
Method of addition of bromocriptine to the drug regime of patients with advanced Parkinson's disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1981, Volume: 8, Issue:1

    Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1981
Parkinson's disease: new treatments.
    Comprehensive therapy, 1981, Volume: 7, Issue:4

    Topics: Acetylcholine; Amantadine; Apomorphine; Bromocriptine; Carbidopa; Counseling; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Parkinson Disease; Physical Therapy Modalities; Receptors, Dopamine; Thalamus

1981
Further experiences with low doses of bromocriptine in Parkinson's disease.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Bromocriptine; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease

1980
The role of bromocriptine in the treatment of Parkinson's disease.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Bromocriptine; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Middle Aged; Parkinson Disease

1980
A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1980
Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro.
    Brain research, 1994, Sep-19, Volume: 657, Issue:1-2

    Topics: Animals; Bromocriptine; Carbidopa; Corpus Striatum; Desipramine; Dopamine; Free Radical Scavengers; Hydroxyl Radical; Injections, Intraventricular; Levodopa; Male; Mice; Mice, Inbred ICR; Oxidopamine

1994
Management of neuroleptic malignant syndrome--a series of eight cases.
    The Journal of the Association of Physicians of India, 1993, Volume: 41, Issue:2

    Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; Humans; India; Levodopa; Male; Muscular Diseases; Neuroleptic Malignant Syndrome

1993
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease

1994
Dopaminergic hallucinosis with fluoxetine in Parkinson's disease.
    The American journal of psychiatry, 1993, Volume: 150, Issue:11

    Topics: Aged; Bromocriptine; Carbidopa; Fluoxetine; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Visual Perception

1993
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.
    Annals of neurology, 1993, Volume: 34, Issue:5

    Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM

1993
Combination therapy for PD.
    Neurology, 1993, Volume: 43, Issue:12

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic

1993
Locally formed dopamine modulates renal Na-Pi co-transport through DA1 and DA2 receptors.
    The Biochemical journal, 1995, Dec-01, Volume: 312 ( Pt 2)

    Topics: Adenylate Cyclase Toxin; Animals; Benserazide; Bromocriptine; Calcium; Carbidopa; Carrier Proteins; Cell Line; Cyclic AMP; Dopamine; Kidney Tubules, Proximal; Kinetics; Levodopa; Opossums; Parathyroid Hormone; Pertussis Toxin; Phosphates; Receptors, Dopamine D1; Receptors, Dopamine D2; Sodium; Sodium-Phosphate Cotransporter Proteins; Symporters; Virulence Factors, Bordetella

1995
Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
    Life sciences, 1997, Volume: 61, Issue:26

    Topics: Animals; Bromocriptine; Carbidopa; Catalepsy; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Motor Activity

1997
Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:3

    Topics: Adult; Antiparkinson Agents; Brain Edema; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Magnetic Resonance Imaging; Male; Methanol; Parkinson Disease, Secondary; Putamen; Tomography, X-Ray Computed

1999
Influence of dopamine energic pharmacology drugs on secretion of the adrenocorticotropic hormone from the hypophysis.
    Microbios, 2000, Volume: 102, Issue:403

    Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Carbidopa; Dopamine; Dopamine Agents; Drug Therapy, Combination; Levodopa; Male; Pituitary Gland; Rats; Rats, Wistar

2000
Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Sep-15, Volume: 22, Issue:18

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Chlorocebus aethiops; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Electrodes, Implanted; Female; Globus Pallidus; Levodopa; Neurons; Organic Chemicals; Parkinsonian Disorders

2002
Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire international, 2005, Volume: 14, Issue:76

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Catechols; Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Dyskinesias; France; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease

2005
Pathological hypersexuality induced by dopamine replacement therapy in a patient with progressive supranuclear palsy.
    The Journal of neuropsychiatry and clinical neurosciences, 2008,Fall, Volume: 20, Issue:4

    Topics: Aged, 80 and over; Bromocriptine; Carbidopa; Dopamine Agents; Humans; Male; Paraphilic Disorders; Supranuclear Palsy, Progressive

2008